Chargement en cours...
Treatment-free remission in CML: who, how, and why?
Chronic myeloid leukemia (CML) is the best example of successful targeted therapy. Today, the overall survival of patients with CML treated by using tyrosine kinase inhibitors (TKIs) is very close to that of the healthy population. The current question is: how can we further ameliorate the clinical...
Enregistré dans:
| Publié dans: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142562/ https://ncbi.nlm.nih.gov/pubmed/29222243 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|